Hidden Burden
1 in 4 Canadians has a degree of depression serious enough to need treatment in their lifetime
Global Disease
Over 4M Canadians and 300M people worldwide (2018) are affected by the disease
Treatment Resistance
30-60% of depression patients are treatment resistant (TRD)
Cost
TRD costs Canadian economy $32.3B each year (lost productivity and health care cost).
North America
North America (US) makes the top 5 regions affected by the disease
rTMS is an innovative, non-invasive treatment for many mental health disorders widely used in the US and Europe to treat depression but the present solutions are bulky and require a hospital, university or well-equipped private clinic to conduct the treatment
–> rTMS uses magnetic pulses directed into the brain to alter neuronal responses
–> rTMS has proven effective in countless clinical trials around the world over many years
–> rTMS has essentially zero side effects
–> rTMS is approved by FDA and Health Canada
The unique technology (patent pending) allows the use of household voltage and thus permits remote treatments at 1/4 the cost of institutional units
Because of the unique coil design and proprietary circuitry, our device can literally be plugged into the wall (120V) and used in the comfort of a home
More powerful than battery operated depression treatment devices and is as powerful as clinically used rTMS machines
Two main components (coil and power supply) allow for lower device cost overall.
CSA /TUV approval for small batch production for clinical testing in controlled setting (eg patient safety, electrical interference)
Clinical trials begin / Demo sites arranged with key stakeholder groups (hospitals and existing rTMS clinics in Canada)
End of clinical trials / FDA approval
Volume manufacturing and ISO/worldwide approvals / Marketing, training, installation
George Hathaway, PEng is responsible for scientific and engineering “hands-on” project management from concept to completion and is the chief designer with final oversight and accountability whilst focusing on the overall company growth.
Joe has engineered and managed various projects including the design of the power supplies which support the aircraft and radar systems aboard the CN77 aircraft carrier and the first test platform for the F35 fighter; he is accustomed to various specifications such a CSA, UL, CE, SEMI S2 and military specs.
Iana Dogel, PhD, MBA worked on commercialization of a micro-fluidic technology out of the University of Toronto, took nanotechnology-based start-ups to the international markets, and performed companies’ due diligence and technology assessments (life sciences) for successful investments.
Jim Segala holds advanced degrees in both Mechanical Engineering and Physics which allows him to engage in a wide range of areas where he can utilize his expertise. Dr. Segala has performed computational chemistry, biology, electrodynamic, and mechanical system analysis.